| NDC Code | 0023-3921-02 |
|---|
| Package Description | 1 VIAL in 1 CARTON (0023-3921-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
|---|
| Product NDC | 0023-3921 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Botox |
|---|
| Non-Proprietary Name | Onabotulinumtoxina |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRADERMAL; INTRAMUSCULAR |
|---|
| Start Marketing Date | 20100111 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA103000 |
|---|
| Manufacturer | Allergan, Inc. |
|---|
| Substance Name | BOTULINUM TOXIN TYPE A |
|---|
| Strength | 200 |
|---|
| Strength Unit | [USP'U]/1 |
|---|
| Pharmacy Classes | Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC] |
|---|